June 04, 2026
The simulators market size is forecast to increase from USD 14.71 billion in 2026 to USD 27.59 billion by 2035...
Read MoreApril 21, 2026
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreJanuary 19, 2026
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 266.5 billio...
Read MoreApril 21, 2026
The cardiometabolic diseases market size is anticipated to grow from USD 292.04 billion in 2026 to USD 1987.69...
Read MoreApril 21, 2026
Forecasts suggest that the non-oncology precision medicine market will expand from USD 83.87 billion in 2024 to USD 193.16 billion by 2034, with a CAGR of 8.7% during this period. Non-Oncology Precision Medicine tailors treatments to individual patients based on their genes, lifestyle, and environment, focusing on conditions like cardiovascular, me...
April 21, 2026
According to market projections, the lung disease therapeutics sector is expected to grow from USD 91.36 billion in 2024 to USD 165.17 billion by 2034, reflecting a CAGR of 6.1%. Lung disease therapeutics focus on treating conditions like asthma, COPD, pulmonary fibrosis, and infections. These treatments include inhalers, medications, oxygen therap...
April 21, 2026
Market insights predict the brain implants industry will increase from USD 7 billion in 2024 to USD 17.02 billion by 2034, achieving a CAGR of 9.3%. The brain implants market is growing rapidly, driven by advances in neurotechnology and increasing demand for treatments for neurological disorders like Parkinson’s, epilepsy, and paralysis. Inno...
April 21, 2026
The global over-the-counter (OTC) analgesic market, valued at USD 30.61 billion in 2024, is anticipated to reach USD 44.02 billion by 2034, growing at a CAGR of 3.7% over the next decade. An over-the-counter (OTC) analgesic is a pain-relieving medicine you can buy without a prescription. It helps reduce pain, fever, or inflammation and includes com...
April 21, 2026
Projections indicate that, antacids industry is projected to rise from USD 7.47 billion in 2024 to USD 10.33 billion by 2034, reflecting a CAGR of 3.30% over the next decade. The antacids market is growing due to rising acid reflux and GERD cases from sedentary lifestyles, an aging population, and increased R&D for novel formulations. Widely us...
April 21, 2026
The U.S. home infusion therapy industry is projected to rise from USD 19.56 billion in 2025 to USD 36.88 billion by 2035, reflecting a CAGR of 7.3% over the next decade. Home infusion therapy in the U.S. lets patients receive medications like antibiotics, pain management, or nutrition through an IV at home instead of a hospital. It’s a conven...
April 21, 2026
Market insights predict the global corticosteroids industry will increase from USD 5.2 billion in 2025 to USD 8.55 billion by 2035, achieving a CAGR of 5.10%. Corticosteroids are anti-inflammatory drugs that help reduce swelling, redness, and immune responses. They treat conditions like asthma, arthritis, allergies, and autoimmune diseases. Availab...
April 21, 2026
According to market projections, the retinitis pigmentosa sector is expected to grow from USD 14.89 billion in 2024 to USD 27.17 billion by 2034, reflecting a CAGR of 6.2%. In 2023, Autosomal Recessive RP dominated with 65% market share, but gene therapy is gaining traction at 23%, bringing new hope. North America leads the market, yet Asia Pacific...
April 21, 2026
According to market projections, the ulcerative colitis treatment sector is expected to grow from USD 10.58 billion in 2024 to USD 15.81 billion by 2034, reflecting a CAGR of 4.1%. The battle against ulcerative colitis is heating up! Pancolitis, the most widespread form, accounted for 34% of cases in 2023. Anti-TNF biologics lead treatment options ...
April 21, 2026
Market insights predict the global nanomedicine industry will increase from USD 241.49 billion in 2024 to USD 632.09 billion by 2034, achieving a CAGR of 10.1%. In 2024, North America led the market, while Asia-Pacific is the fastest-growing region. Drug delivery dominated by application, but therapeutics is set for rapid growth. Clinical oncology ...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
